A: Agilent Corp Cash Calculated per Single Share

Agilent Technologies is overcoming a slump in biopharmaceutical capital expenditures, as evidenced by the cash per share on this GURU.Markets chart, where 6.24 reflects the latest metric value. Moderate demand cyclicality is offset by stable sales of consumables, although US export barriers and electronics supply chain challenges in Asia create certain operational risks.
Analytical breakdowns for Agilent Technologies
- share price and expert price forecast:
- market capitalization information:
- book capitalization indicators:
- debt and solvency information:
- business earnings and investment ratios data:
A - Net Profit|Projected Net Profit Agilent Technologies|A - P/E Multiple|Market Cap to Projected Earnings Agilent Technologies|A - PEG Multiple|Company Value to EBITDA Agilent Tech|A - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Agilent|A - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth agilent.com|A - Earnings per share growth in current year|Expected earnings per share growth for next year Agilent Technologies
- company sales and revenue statistics:
- margin ratios data:
- cash position and cash flow details:
Comprehensive company analysis:A (Agilent Corp)

Strategic continuity at Agilent Technologies (A) during leadership transitions ensures operational culture stability and a high level of market confidence. By analyzing changes in cash per share, investors assess the business's liquid reserve, which serves as a buffer against external shocks, although excessive cash holdings may constrain the overall return on equity.
Analysis of competing companies
DGX: Amount of Cash per Share|Cash per Share ILMN|EXAS (exactsciences.com) - Amount of Cash per Share|Revvity Corp - Cash per Single Share|Amount of Cash per Share BIO|Anbio Corp - Cash per Share|Cash on Hand per Share Sterigenics|QDEL (QuidelOrtho Corp) - Cash per Single Share|OPK: Cash Calculated per Single Share|CDNA (CareDx) - Cash per Share|Maravai LifeSciences Holdings, Inc. (MRVI) - Cash Funds Calculated per Share|Cash Funds per Share Fulgent Genetics, Inc. (FLGT)|LAB - Cash on Hand per Share|Cash per Share CTKB (cytekbio.com)|Amount of Cash per Share OSUR|XGN - Cash Funds per Share|MDxHealth (MDXH) - Cash per Single Share|LUCD (Lucid Diagnostics) - Cash per Single Share|Prenetics Global Ltd (PRE) - Cash per Share|Cash Funds per Share Insight Molecular Diagnostics|TRIB: Amount of Cash per Share|Cash Funds per Share ProPhase (PRPH)|AIMD - Cash on Hand per Share|Cash Funds per Share Co-Diagnostics, Inc. CODX|Cash per Share Heart Test Laboratories HSCS|Biomerica Inc - Cash per Share|Cash Funds Calculated per Share cardiodiagnosticsinc.com CDIO|Onconetix Inc (ONCO) - Cash Funds per Share|Cash Money per Share VRAX (Virax Biolabs Group Ltd)|BJDX (Bluejay) - Cash per Share|Cash per Share Aspira Women's Health|Cash per Share AXDX|CENTOGENE - Cash Funds per Single Share|Cash per Share ENZ (enzo.com)|Cash per Share Fresh2 Group Ltd FRES|GENE - Cash Funds per Share|ME (23andMe Inc.) - Cash Funds per Single Share|PMD: Cash per Share